key: cord-0825727-rgspccso authors: Sattari, Shabnam; Adeli, Mohsen; Beyranvand, Siamak; Nemati, Mohammad title: Functionalized Graphene Platforms for Anticancer Drug Delivery date: 2021-08-30 journal: Int J Nanomedicine DOI: 10.2147/ijn.s249712 sha: 096b2103dafb60fd66e6ae919f53c26c6782debd doc_id: 825727 cord_uid: rgspccso Two-dimensional nanomaterials are emerging as promising candidates for a wide range of biomedical applications including tissue engineering, biosensing, pathogen incapacitation, wound healing, and gene and drug delivery. Graphene, due to its high surface area, photothermal property, high loading capacity, and efficient cellular uptake, is at the forefront of these materials and plays a key role in this multidisciplinary research field. Poor water dispersibility and low functionality of graphene, however, hamper its hybridization into new nanostructures for future nanomedicine. Functionalization of graphene, either by covalent or non-covalent methods, is the most useful strategy to improve its dispersion in water and functionality as well as processability into new materials and devices. In this review, recent advances in functionalization of graphene derivatives by different (macro)molecules for future biomedical applications are reported and explained. In particular, hydrophilic functionalization of graphene and graphene oxide (GO) to improve their water dispersibility and physicochemical properties is discussed. We have focused on the anticancer drug delivery of polyfunctional graphene sheets. Cancer is a general name for a group of more than 100 diseases and one of the most serious health risks that is the second-leading cause of death worldwide behind cardiovascular disease. [1] [2] [3] [4] [5] Cancer is usually caused by abnormal proliferation of different cells in the body that differ significantly in the complexity of treatment. Abnormal cell proliferation leads to tumor formation that can be benign or malignant. A benign tumor (non-cancerous) is not cancerous and remains confined to its original site and does not metastasize to other regions of the body. However, a malignant tumor (cancerous) is an invasive tumor and spreads through the bloodstream or lymphatic system throughout the body. Benign tumors can usually be removed by surgery, but malignant tumors are often resistant to current treatments and are much more dangerous because of their ability to invade and metastasize to different parts of the body. 6, 7 Many research studies have focused on finding new strategies to reduce the side effects of conventional therapies. [8] [9] [10] Despite its drawbacks and limitations, chemotherapy plays a significant role in cancer treatment. 11 One of the main challenges associated with chemotherapy is low bioavailability of chemotherapeutic agents and drug-resistant tumor cells. [12] [13] [14] Nanomaterials, due to their unique physicochemical properties, including shape, surface, size, and optical properties, are able to target cancerous tissue and cross the biological barriers with minimal side effects. 8, 15, 16 Different types of nanomaterials such as organic nanoparticles (polymeric micelles, liposomes, and dendrimers) inorganic nanoparticles (quantum dots, carbon nanotubes, magnetic and metal nanoparticles), 2D nanomaterials (graphene and its derivatives, molybdenum disulfide, boron nitride, black phosphorus nanosheets, transition-metal dichalcogenides, transition metal oxides, metal organic frameworks, layered double hydroxides), nanocomposites, and nanogels have been used for this purpose. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] To address these problems, anticancer drug delivery systems based on two-dimensional nanomaterials are developed and their ability to target anticancer drugs into tumors is investigated. 29 Graphene-based nanomaterials due to their excellent physicochemical and biological properties including high loading capacity, photothermal property, and fast cellular uptake have been used to improve current chemotherapies. [30] [31] [32] [33] In this review, we have focused on the functionalized graphene sheets as nanocarriers to transport therapeutic agents into tumors along with a brief discussion on the challenges and future trends in this field. Graphene is a two-dimensional honeycomb network with sp 2 carbon atoms. Each atom is bonded to neighboring carbons by σ-bond and out of plane p orbitals are extended over the whole structure. Graphene could be considered as the main backbone of various allotropes of carbon including fullerene, zero dimension (0D), nanotubes, one dimension (1D), and graphite, three dimensions (3D) 34 (Figure 1 ). The unique physicochemical, optical, electrical, and mechanical properties of graphene make it a suitable platform for various applications such as energy storage, 35, 36 sensors, [37] [38] [39] biological and medical applications, [39] [40] [41] [42] [43] [44] [45] [46] cancer therapy, 47, 48 functional devices, [49] [50] [51] and drug delivery. [52] [53] [54] High thermal and electrical conductivity, high elasticity and flexibility, and large surface area are some graphene properties superior to other nanomaterials. 55, 56 Due to its outstanding properties such as photothermal property, oxidative reactivity, and low price, graphene can be used as an appropriate platform for drug delivery. Also, layer structure of graphene represents a high loading capacity for therapeutic agents. 57 Despite the extraordinary properties of graphene, one of the main drawbacks of using it for drug delivery is the low dispersibility of this compound in aqueous solutions. Oxidation to graphene oxide (GO), production of reduced graphene oxide (rGO) or functionalization by hydrophilic functional groups are the main strategies to overcome this problem ( Figure 2 ). GO, an oxidized derivative of graphene, consists of a large number of oxygen containing functionalities such as epoxide, hydroxyl, and carboxylic acid. While epoxide and hydroxyl groups are placed in the basal plane, carboxylic groups are placed along the edges. These functional groups improve dispersibility of GO in water. rGO has much less epoxy due to reduction and it shows a low dispersibility in aqueous solutions. However, one of the main concerns regarding biomedical applications of graphene is the intrinsic toxicity and health risk of this compound. [58] [59] [60] [61] The toxicity of graphene-based nanomaterials mainly depends on different factors including size, surface charge, shape, number of layers, surface functional groups, and particulate state. 58, [62] [63] [64] While some studies showed no toxicity and side effects of graphene on mouse cells, others indicated considerable toxicity for graphene. [65] [66] [67] This discrepancy come back to the variation in the structure of graphene derivatives and necessitates more extensive studies to conclude on the toxicity of graphene and its derivatives. Therefore, before any medical applications, a deep understanding of the toxicological profile of graphene-based nanomaterials is required. Cellular studies have shown that graphene and its derivatives can destroy the structures of the cells. For example, graphene caused plasma membrane damage in Hep G2 cells and induced disintegrate the mitochondrial membrane in a dose-time and shape-dependent manner. 68, 69 Moreover, graphene-based nanomaterials led to DNA fragmentation and chromosomal aberrations in human mesenchymal stem cells and cause side effects in normal cells such as immune system cells. 70, 71 Graphene causes apoptosis by inducing mitogen-activated protein kinases and the transforming growth factor-β-related signaling pathways. 72 Graphene-based nanomaterials have shown dose-dependent hemolytic activity and aggregated graphene particles have shown considerable toxicity. Some studies have shown that graphene and its derivatives increase intracellular ROS and cause cytotoxicity and induce oxidative stress through which proteins, DNA, and lipid destruction have been damaged. [73] [74] [75] [76] [77] Robert Langer and co-workers played with the functionality of graphene oxide and studied the toxicity effects of different types of graphene oxide on mice. The aim was to find a possible relationship between the amount of oxygen containing functional groups and biocompatibility of graphene oxide. Their results showed that by injecting graphene oxide, this substance becomes a mass in the body. The team found that the mice's body excreted graphene oxide over time. Researchers have used standard arrays to study the toxicity effects of graphene oxide and have shown that concentrations less than 1 mg/mL do not show considerable toxicity effects but higher concentrations are toxic to the body. Administration of GO in mice has resulted in chronic toxicity and death from pulmonary granuloma. In addition, dose-dependent pulmonary toxicity, granulomatous lesions, pulmonary edema fibrosis, and inflammatory cell infiltration have also been observed after administration of GO. A pulmonary inflammatory response was also observed in rats after administration of graphene with BSA. [78] [79] [80] [81] Functionalization of graphene with different functional groups can potentially improve the bioavailability, circulation lifetime and anticancer property of this material. 82, 83 As previously mentioned, one way to achieve this goal is functionalization of graphene surface by suitable polymers. 84 Modification of graphene surface by polymers enhances biocompatibility and circulation times of graphene in vivo. PEG is the most studied polymer for the modification and improvement of biological properties of graphene derivatives. Conjugation of PEG onto graphene sheets reduces toxicity and increases stability of graphene under physiological conditions. 85, 86 According to the hematological analysis and histological examinations, nanographene modified PEG do not cause appreciable toxicity at dose (20 mg/kg) in a period of 3 months. 87 Pharmacokinetics and clearance of graphene nanomaterials from the body has been studied but it needs extensive investigations to achieve a deep understanding of the long-term toxicity of these materials. 88, 89 The physicochemical properties of graphene derivatives including size, surface charge, surface chemistry, and shape impact their pharmacokinetics dramatically. 90 Transmission electron microscope (TEM), Raman spectroscopy, isotopic labeling, and rare-earth elements labeling are some of the methods available for tracking these materials in body. 87, [91] [92] [93] For example, Liang et al used the La/Ce dual elemental labeling method to track the bioaccumulation, transfer, and clearance of polyvinylpyrrolidone (PVP) modified GO in vivo. 94 They showed that injected PVP/GO mainly accumulate in the lungs, liver, and spleen, then pass through the glomerular filtration barrier (GFB) of the kidney and can be cleared, likely by both renal and fecal excretion. Similar results have been reported for injected PEGylated 125 I-labeled nanographene sheets. 87 Injected PEGylated graphene are accumulated in the reticuloendothelial system and gradually cleared from the bloodstream through their sequestration by cells of the mononuclear phagocyte system. For many biological applications and in order to improve the functionality and dispersibility of graphene, surface of this nanomaterial should be modified and functionalized. Surface modification of graphene platforms using biocompatible polymers endow new properties and effectively improve their performances for biomedical applications. Taking advantage of the huge conjugated π-systems, high specific surface area, and useful functionality, graphene platforms can be used as novel nanocarriers for different therapeutic agents. [95] [96] [97] [98] Incorporation of polymeric systems into the graphene structure allows tailoring these platforms into new multifunctional systems to deliver a variety of moieties such as therapeutic, targeting, and diagnostic agents. 97, 99 Non-covalent and covalent functionalization are two major strategies for the modification of graphene and its derivatives. [100] [101] [102] [103] [104] [105] [106] Graphene derivatives can be covalently modified by covalent attachment of polymers through addition of free radicals or dienophiles to their C=C bonds. Macromolecules can also be conjugated to GO through silanization, amidation, esterification, and cycloaddition reactions. 107, 108 However, challenges have to be addressed regarding non-destructive and covalent functionalization of graphene derivatives, as the methods previously mentioned cause disruption of sp 2 network and electronic and optoelectronic features of these graphene-based platforms. 109, 110 We have previously developed a nondestructive covalent method for the controlled functionalization of nanographene sheets through nitrene [2+1] cycloaddition reaction based on azidodichloro-triazine at ambient conditions. 111, 112 This strategy allows the controlled non-destructive functionalization of graphene with different polymers and (macro)molecules through conjugated triazine groups and opens up new avenues to construct complex devices for future biomedical applications 112 (Figure 3 ). Non-covalent functionalization by supramolecular interactions including, π-π stacking, hydrogen bonding, and van der Waals force is another strategy for the modification of graphene and its derivatives. While this approach preserved the π-conjugation and the electronic properties of graphene-based materials, it is unstable and functional groups can be detached upon changes in the environmental conditions. 107, 108 In the past several years, various types of graphenepolymer platforms have been developed and investigated as nanocarriers for therapeutic agents. Poly(ethylene glycol) (PEG), 43, [113] [114] [115] polyethylenimine (PEI), 116, 117 chitosan, 118 5958 common polymers that are employed for surface functionalization of graphene derivatives. Dendrimers and hyperbranched polymers, including polyamidoamine 100,122 and polyglycerol 9, 33, 100, 123 are other types of polymeric systems that are commonly used in this field. Polymers significantly improve the physicochemical properties, solubility, stability, biocompatibility, and drug loading capacity of graphene. Cancer is a major cause of death worldwide and prevention or therapy of this disease is one of the biggest health challenges nowadays. Chemotherapy has been used extensively to treat many types of cancer; however, it is limited by different factors including multidrug resistance, systemic toxicity, immunogenicity, and bioavailability. These limitations could be overcome by drug delivery systems. [124] [125] [126] Among drug delivery systems and breakthroughs, graphene and its derivatives have been abundantly used for a wide range of biomedical applications owing to their sheet-like structure, high specific surface area, and ease of functionalization. 99, 127, 128 Due to the availability of different functionalization strategies and taking advantage of the multifunctionality of graphene and its derivatives, various drug delivery systems with controllable biological properties can be prepared. Functionalization of graphene derivatives with various polymers could potentially improve their reactivity, biocompatibility, circulation times in vivo and anticancer capacity. Graphene-polymer platforms with high drug loading capacity have opened up new opportunities in the development of novel drug delivery systems for various biomedical applications, where conventional graphene and polymer alone cannot meet all requirements. 32, [129] [130] [131] Functionalization of graphene and its derivatives with PEG have been extensively used for the construction of anticancer drug delivery systems. 113 Liu et al initially reported PEG-decorated GO as a nanocarrier to effectively deliver anticancer drugs. They exploited non-covalent interactions to load anticancer hydrophobic drugs and found that the combination of PEG with graphene-based materials can effectively improve biocompatibility, cellular uptake, bioavailability, physiological stability, therapeutic efficacy, and circulation time of drugs in bloodstream. 132 On the other hand, PEGylation of graphene reduces aggregates of graphene in RES organs (lungs, liver, spleen, and kidney) as well as its retention and toxicity. Similarly, in another report, 6-armedPEGfunctionalized graphene oxide-based nanocarrier has been reported to deliver anticancer drugs such as oridonin and methotrexate (MTX). 133 Synthesis of PEG-grafted GO and loading of drugs has been performed via amidation and ππ stacking, respectively. This complex (oridonin or MTX@GO-PEG) exhibited higher cellular uptake and anticancer activity against CAL27 tumor cell in comparison with free drugs. PEGylated graphene has also been developed as dual-drug (DOX and platinum) delivery system with a higher efficiency than the single-drug system. 113 The results of these studies showed that the combination of drugs efficiently overcomes the cancer drug resistance and improves their anti-cancer effect. This drug delivery system demonstrated less toxicity and damage to normal cells compared to DOX and platinumfree drugs. Interactions of PEGylated graphene with drugs have been adjustable by polymer chain length. 134, 135 In another study, PEGylation of GO using PEG copolymer conjugated to multiple pyrenes increased percentage of PEG on GO surface and simultaneously reduce GO to rGO. In-vitro assays of this study revealed that graphene with PEG content higher than 75% and longer PEG chain showed better physicochemical properties than their analogs with shorter PEG chains. 134 The combination of PEG with other polymers such as hyaluronic acid, polyethyleneimine, and chitosan have also been intensively investigated in order to improve therapeutic effects of graphene-drug platforms. [34] [35] [36] [37] [38] 136 PEI a cationic polymer is another type of widely explored polymers for the surface modification of graphene-based materials. 116, 137, 138 It was found that bare PEI with high molecular weight induced high cytotoxicity due to high cellular uptake and low biodegradability, while its hybridization with carbon materials resulted in a low cytotoxicity. Commonly, PEI is able to form a complex with graphene derivatives via electrostatic interactions and amination methods. PEI-graphene are cationic platforms with multiple advantages including high hydrophilicity, biocompatibility, strong binding to nucleic acids, effective cell uptake, and thermal stability. We report that co-delivery of therapeutic genes and chemotherapy downregulates tumor cell resistance to anticancer drugs and overcome multidrug resistance (MDR). 139, 140 PEI-conjugated graphene has been developed for co-delivery of DOX drug and p53 tumor suppressor gene in order to inhibit HeLa cell growth. Owing to presence of PEI cationic polymer and synergistic effect of drug and gene, DOX/GO-PEI/p53 complex has been efficiently internalized into HeLa cells via endocytosis and has exhibited higher growth inhibition than the single drug/gene delivery system. 141 In 2019, Mallick et al developed an interesting polymer-graphene platform based on self-assembled PEI covered graphene oxide nanoparticle (PEI-GTC-NP) for codelivery of cisplatin and topotecan into mitochondria. This platform is able to target drugs into mitochondria of cancer cells effectively. Reactive oxygen species (ROS) were generated at specific sites in mitochondria, which in turn led to apoptosis of cancer cells (Figure 4 ). 116 Topotecan have been loaded on GO by π-π stacking to visualize nanomaterial in cancer cell's mitochondria by fluorescence emission. Cisplatin was also applied as chemotherapy medication to treat cervical cancer. Localization of PEI-GTC-NPs into cancer cell resulted in mitochondrial membrane perforation. MTT assay indicated that the half maximal inhibitory concentration (IC 50 ) for nanoparticles in the absence of PEI (GTC-NPs) is higher than PEI-GTC-NPs. This nanoparticle with positive surface charge and suitable size has been able to penetrate into mitochondria of cancer cells specifically and has shown good potential for treatment of cancer. Natural biopolymers owing to their low toxicity, biodegradability, renewability, environmental sensitivity, and biocompatibility are also promising materials to improve the biological properties of graphene-based materials. [142] [143] [144] [145] Chitosan with anticancer activity and as a pH sensitive polymer has been widely employed in the synthesis of polymergraphene hybrids. [146] [147] [148] The produced multifunctional scaffolds have exhibited high loading capacities and functional binding sites for different types of drugs and targeting ligands. [147] [148] [149] Moreover, graphene-chitosan platforms have been widely studied as a pH-sensitive nanovehicle for the targeted release of drugs into cancer cells. Graphene oxidechitosan hybrids have been developed by Dhanavel and coworkers for the controlled delivery of 5-Fluorouracil (5-FU) and curcumin (CUR). These systems have been synthesized https://doi.org/10.2147/IJN.S249712 International Journal of Nanomedicine 2021:16 5960 by conjugation of chitosan to GO nanosheet through tripolyphosphate as a crosslinker. Chitosan/reduced graphene oxide (CS/rGO) has displayed pH-dependent drug release behavior. In 2018, Zhao et al reported a chitosan-graphene drug delivery system. It was a core-shell structure containing graphene oxide nanoparticles (GONs) as core and chitosan as surface charge-reversible shells, which was deposited on graphene core via self-assembly ( Figure 5 ). 150 Doxorubicin (DOX) via the non-covalent interactions (π-π stacking) bound to the large π conjugated system of GO and chitosan shells prevents premature secretion of loaded DOX in the medium. Due to the lower pH in cancerous tissue, the coated chitosan was separated, thus accelerating the release of DOX. The charge of these nanomaterials changes from negative at pH= 7.4 in the bloodstream to positive at pH 6.5 in the tumor tissue. Chitosan-graphene platform showed advantages over the usual drug delivery systems including high drug loading capacity (DL), great encapsulation efficiency (EE), long-time circulation in bloodstream, improved cellular uptake, and adjustable controlled release of anticancer therapeutics. While CS has been widely explored in biomedical and environmental fields, there have been some limitations including insolubility at neutral pH and low rate of degradation. 148 These problems have been overcome by combining CS with other biopolymers such as cellulose, dextrin, sodium alginate, and so on. [151] [152] [153] [154] Multilayers of biopolymers can be disposed of on graphene through various techniques. 155, 156 In a study, layer-by-layer (LbL) self-assembly technique has been explored for deposition of CS and dextrin on graphene surface. 157 In this process GO has been first modified with CS, followed by conjugation of dextrin (Dex) via electrostatic interaction with oppositely charged polyelectronic. The GO-CS/Dex conjugate has shown high drug loading capacity, physiological stability, and cellular uptake, compared with GO-CS. In another study, CS has been modified by poly(itaconic acid-copolymerized acrylic acid) in order to increase hydrophilic nature of chitosan. 53 This new combination has been used for the modification of GO-amine (AGO) with anticancer drug delivery application. CS-GO hybrid has been prepared via electrostatic interactions between chemically modified chitosan as an anionic polyelectrolyte and AGO which acts as a cationic polyelectrolyte. 118 Omidi et al, 119 Samadi et al, 158 and Lei et al 159 have also verified improvement of physicochemical and biological properties of graphene-chitosan composites through integration with other polymers. HA is recognized as another important polysaccharide for the improvement of the biological properties of graphene- based materials. 121, 160, 161 Biomedical applications of HA and its usage for the production of anticancer drug delivery systems have been widely developed, due to its excellent biocompatibility, biodegradability, as well as strong binding affinity and selective targeting of tumor markers, especially the cluster determinant 44 (CD44) and hyaluronan receptor (HARE). [162] [163] [164] Yin's group has prepared redox-sensitive hyaluronic acid-graphene oxide (HSG) composite and studied its ability to target HA-receptor overexpressing tumors and efficiency of redox-sensitive linkages to localize drugs at the target sites. This system was synthesized by conjugation of hyaluronic acid to GO nanosheet using disulfide linkages (HSG). HSG-DOX displayed accelerated release of DOX in acidic environments. Because high activity of hyaluronidase (HAase) in acidic conditions resulted in degradation of hyaluronic acid chains into small pieces and promoted release of DOX. Owing to high drug-loading capacity, photothermally controlled effects, specific targeting of HA receptors overexpressing tumors, and redox-dependent response, HSG-DOX showed amplified chemotherapeutic outcomes. 161 Dendrimers and hyperbranched polymers, especially polyglycerol, are able to effectively improve biological properties and biofunctionality of graphene sheets, as demonstrated in our previous studies. 51, 100, 103, 112, 131, [165] [166] [167] Our group implemented a new method for functionalization of graphene-based nanomaterials with hyperbranched polyglycerol. 14 Thermally reduced GO was functionalized by triazine and consequently conjugated with hyperbranched polyglycerol through triazine functional groups. The polyglycerol-covered nanographene with mitochondria-targeted ligands and pH-triggered surface charges showed a high loading capacity and triggered release of DOX drug in the acidic environment ( Figure 6 ). Owing to photothermal properties of nanographene, this multifunctional drug delivery system exhibited accelerated drug release and enhanced chemotherapeutic effect after NIR irradiation. The authors concluded that the high accumulation of smart multifunctional drug delivery system in mitochondria and nucleus, together with photothermal properties, were the reasons for the enhanced chemotherapeutic effects. 14 One of the cancer treatment methods that has received a great deal of attention is targeted delivery in which anticancer drugs are transported to the target tissues specifically. The method is designed by attaching targeting agents to nanocarriers. Targeting drug delivery systems increases the localization of drugs at tumor sites and diminishes the side effects of chemotherapies. Accordingly, a drug delivery system with targeting ligands and good emission property in visible and infrared has been prepared by loading anticancer drugs onto NGO. 168 Zhang et al have developed GO as a drug delivery system by loading DOX and Camptothecin (CPT) on its surface and conjugation of folic acid to transport cargos to the tumor sites. FA-conjugated NGO (FA-NGO) was able to target MCF-7 cells, and human breast cancer cells by interaction with FA receptors. 68 Some superparamagnetic nanocarrier based on attaching Fe 3 O 4 as a magnetic nanocarrier on GO and aptamer (APT) as a targeting moiety for MCF-7 cancer cell is prepared and then, paclitaxel (PAC) is loaded as an anti-cancer drug. This system has shown advantages including biocompatibility, pH-responsivity, thermal stability, and high drug loading capacity over similar nanocarriers. 169 A rGO-based system with the ability to deliver DOX to human breast adenocarcinoma cancer cells (MDA-MB-231) is also reported. In this system, a thiol maleimide containing catechol (dopa-MAL) is assembled on the surface of rGO by π-π stacking. Then, a cancer cell targeting cyclic peptide is attached to dopa-MAL. This nanostructure has shown a high efficiency against MDA-MB-231 cells with an IC50=58 µg mL −1 for DOX-loaded rGO/dopa-MAL-c (RGDfC), corresponding to an IC50=9.9 µg mL-1 for DOX in the matrix (Figure 7) . 170 Hyaluronic acid (HA) is also used to target GO into cancer cells. GO with HA functionality (GO-HA) has been coloaded with DOX and paclitaxel (Ptx) and the obtained drug delivery system (GO-HA-DOX/Ptx) has been used for the efficient incapacitation of cancer cells. 170 Another target drug delivery system is designed based on dopamine (DA) functionalized nGO nanocarrier (DA-nGO). DA improves the delivery of methotrexate (MTX) as an anticancer cargo into target cells. 171 Song et al have produced a targeted drug delivery system by loading Fe 3 O 4 nanoparticle on the surface of GO and conjugation of lactoferrin (Lf) as a targeting ligand to this platform. The results have shown that this system (Lf@GO@Fe 3 O 4 @DOX) has the ability to deliver drugs into C6 glioma cells effectively. 172 Conjugation of polymers and targeting ligands onto the surface of graphene derivatives improves the therapeutic efficiency of these platforms by increasing their loading capacity and decreasing their side effect as well as efficient localization of drug delivery systems in the targeted cells ( Figure 8 ). 173 To overcome the limitations of conventional drug delivery systems such as poor tumor penetration, collateral damage to healthy tissues and uncontrollable drug release, stimuliresponsive drug delivery systems, in which therapeutic agents can be activated by endogenous or exogenous stimuli, have been developed. 174, 175 Graphene-based platforms can be excellent candidates in this regard, since they are sensitive to changes in tumor microenvironment/intracellular signals and response to physical stimuli factors. [175] [176] [177] [178] [179] Due to the conversion of glucose to lactose, cancerous tissues are more acidic (pH 6.5-7.2) than both blood and healthy tissues (pH 7.4). Therefore, conjugation of pHresponsive ligands to the platforms results in controlled drug release at tumor sites. [180] [181] [182] Accordingly, graphenepolymer platforms with pH sensitive functional groups (COOH, -NH 2 , and -SO 3 H) have been widely explored to control the release of various therapeutic agents at tumor sites. An example of such systems has been recently reported by our group. 14 Graphene-based drug delivery systems with charge conversional property was synthesized through functionalizing polyglycerol-covered nanographene sheets with 2,3-dimethylmaleic anhydride (GPTD) (Figure 6 ). The surface charge of this system changed from negative at pH 7.4 to positive at pH 6.8. Therefore, it was negatively and positively charged in the blood stream and tumor tissue, respectively. These unique features resulted in a longer-term circulation and increased permeability and retention (EPR) effect of drug delivery systems in body and better localization and controlled release of payloads at tumor sites. This multifunctional drug delivery system showed significant synergistic hyperthermia and chemotherapy effects and showed a high potential in multidrug resistance chemotherapy. 14 Charge conversional graphene platforms are promising nanocarriers for site-specific delivery of drug because of their charge conversion at reduced pH. [183] [184] [185] Our group reported a charge conversional graphene platform to promote cellular uptake of loaded drugs 166 (Figure 9 ). In this work, polyglycerol containing sulfate and amino groups were conjugated to GO surface, yielding charge-conversional systems. The protonation of hPG amine in the acidic environment accelerated the release of DOX due to repulsion between protonated DOX and hPG amine. On the other hand, due to weakening π-π stacking and hydrophobic interactions between the graphene-polymer platforms and doxorubicin, as well as increasing solubility of drug in acidic conditions, effective release of drug occurred in this condition. 166 It is known that antioxidant concentration (such as GSH) in intracellular microenvironment of tumor tissues (1−10 mM) is often higher than that in normal tissues (20 −40 μM). 186, 187 This feature is important in the development of graphene-based smart systems. Internalized graphene-based platforms with disulfide bonds and redox properties are able to deliver drugs and release them at tumor sites efficiently. DOX has been linked to PEG/PCL copolymer via disulfide bonds and then decorated on graphene surface through hydrophobic interactions. The release of drugs from this system was controlled by redox factors such as GSH. 188 Apart from their ability to provide intracellular responsiveness, graphene platforms also have the capability to respond to some exogenous stimuli 189 including light and magnetic fields, which will be discussed later. Bioimaging techniques have a broad range of biomedical applications, from diagnosing diseases to investigating body tissues at the cellular level. 190 Previously, these techniques were mostly used in orthopedic diagnosis. Upon development of imaging tools and methods, other techniques such as magnetic resonance imaging (MRI), X-ray computed tomography (X-ray CT), ultrasound, radio wave technology etc. were also used in various medical fields. 191, 192 Bioimaging by both optical microscopy such as laser scanning confocal microscopy (LSCM) and electron microscopy such as liquid cell electron microscopy (LC-EM) helps to evaluate living tissues with high magnifications. 193, 194 Graphene and its derivatives, due to their interesting optical properties, have shown a high potential in this research field. 195, 196 They can be used for bioimaging in two ways: i) by inherent optical properties such as fluorescence quenching and Raman signals, ii) by loading fluorophores and fluorescent drugs onto their surface. 197, 198 Graphene due to its zero-bandgap energy is not photoluminescent but graphene derivatives such as GO possess a significant band-gap and show the photoluminescence property. 199 They emit a broad range of fluorescence from ultra violet (UV) to NIR. 200 One of the promising properties of graphene derivatives is their ability to quench most types of fluorescence materials. 201 These two features make graphene and its derivatives unique platforms for bioimaging. It is shown that charge transfer from the fluorophore to GO is the main reason for the fluorescence quenching and FERT (resonance energy transfer). 202, 203 Functionalization by a variety of materials, such as polymers, proteins, nucleic acids, peptides, and nanoparticles improves the physicochemical properties of graphenebased bioimaging probes. [204] [205] [206] These compounds improve biocompatibility, loading capacity, water 5966 solubility, specificity, or sensitivity of graphene-based platforms and improve their performance as bioimaging tools. 207 Dong et al have developed a multifunctional graphene quantum dots-polymer for cell imaging. 208 They have used poly(L-lactide) (PLA) and PEG-grafted GQDs for microRNAs imaging analysis ( Figure 10 ). Functionalization of GQDs with these polymers has created a nanocomposite with stable photoluminescence over a wide range of pH, which is extremely important for cell imaging. The results of cell experiments have shown low cytotoxicity and high biocompatibility for this nanocomposite, qualifying it for future bioimaging investigations. Graphene and its derivatives are able to absorb NIR laser irradiation and generate heat efficiently. Therefore, they have been widely used as photosensitizing agents for photothermal therapy. This technique in combination with chemotherapy shows synergic therapeutic effect. [209] [210] [211] [212] [213] [214] Cheon et al have developed a combinational photochemotherapy to enhance therapeutic efficacy of DOX. 215 The bovine serum albumin (BSA)-functionalized rGO (BSA-rGO) nanosheets have exhibited a high loading efficiency for DOX and absorbance of NIR light (5.5 W/cm 2 , 808 nm for 300 s). Due to the increased medium temperature at the tumor site under NIR irradiation, drug has been released from BSA-rGO-DOX and low viability of brain tumor cells with reduced chemotherapy side effects has been observed ( Figure 11) . Moreover, photochemotherapy of DOX loaded PEGylated GO nanosheets and DOX loaded PEGylated mesoporous carbon nanospheres (MCN) against 4T1 cells is investigated. MCN-PEG/DOX and GO-PEG/DOX have shown less toxicity against 4T1 cells than free DOX. However, when these systems are irradiated by NIR laser (1.0 W/cm 2 ) for 3 min, an increase in toxicity has been observed. Additionally, due to higher photothermal conversion efficiency (η) and drug release rate, MCN-PEG/DOX has shown higher anticancer effect than DOX/GO-PEG. 216 A photothermal agent based on folic acid-CS functionalized graphene oxide (FA-CS-GO) with high photostability and tumor-targeting ability has been reported by Jun et al. 217 The hybridization of GO and CS-FA hinders the aggregation of GO, promotes cellular uptake and light absorption in this platform, and enhances the PTT effects of FA-CS-GO. The surface temperature of tumors treated with FA-CS-GO increased to 57.6 °C under laser irradiation (2.0 W/cm 2 ) within 5 min. The viability of tumors treated with FA-CS-GO + laser decreased dramatically, in comparison with laser irradiation in the absence of this platform. The combination of graphene mediated PTT with immunotherapy has resulted in very promising results for the treatment of metastatic tumors. Fe 3 O 4 nanoparticles (FNPs)/rGO/PEG (FNPs/rGO-PEG) nanocomposite are developed as multimodal agents for MRIguided photothermal-immunotherapy. The combination of FNPs/rGO-PEG nanocomposite with NIR light through reduction of tumor macrophages and photothermal therapy has promoted antitumor immune response. 218 The surface tumor temperature in FNPs/ rGO-PEG-injected mice has reached to 59°C after NIR laser irradiation (805 nm, 1 W cm 2 ). 218 Photodynamic therapy (PDT) is an efficient method for tumor suppression. In this strategy, reactive oxygen species (ROS) are generated by photosensitizer (PS) upon visible light or laser absorption and destroy tumor cells at target sites. 219, 220 To control ROS generation and enhance cellular uptake of photosensitizers, reactive agents including porphyrins, chlorins, and dyes are conjugated to graphene platforms. 219, 221, 222 Moreover, multimodal therapies combined with PDT such as chemo-photodynamic therapy (PDT), immunotherapies-photodynamic therapy (PDT), and photothermal therapy (PTT)-photodynamic therapy (PDT) have been used for strong antitumor activity. Nanographene oxides (NGOs) with TPE (AIE) photosensitizers were synthesized as powerful tool for multimodal imaging-guided PDT. 223 NGP-TPEred nanoparticles under 450 nm laser irradiation have shown a significant tumor inhibition both in vitro and in vivo. In another study, the chemo-PDT mediated by photosensitizer indocyanine green (ICG) and folic acid conjugated GO-PEG co-loaded with MTH1 inhibitor (TH287) and DOX has been developed for the targeted therapy of osteosarcoma tumor. MTH1 protein with controlled ROS production has been shown to be a highly synergistic chemo-photodynamic therapy. 224 Furthermore, graphene quantum dots (GQDs) and graphene oxide quantum dots (GOQDs) with the size range of 1.5-5.5 nm have reduced skin cancer (B16F10) cells and Some human diseases stem from defective genes. In gene therapy, effective treatments of genetic diseases, nucleic acids, and genetic materials are encapsulated by nanocarriers and delivered to the desired sites in the cell. 226 Gene delivery is a process through which foreign DNA is transferred into target cells to express an exogenous gene. 227 Due to low bioavailability and enzymatic degradation of DNA, it should be delivered to the cells by a suitable carrier. Gene delivery systems are categorized into: viral, non-viral, and oncolytic viral vectors. 228 Viral gene delivery systems are composed of modified viruses which are not able to replicate. The most studied viral vectors for DNA delivery are including adenoviruses (AV), adeno-associated viruses (AAV), retroviruses (RV), lentiviruses (LV), and herpes simplex viruses (HSV). Their analogs for RNA delivery are human foamy virus (HFV), oncoretro-viral vectors, and lenti-viral vectors. 229 Another type of gene delivery system is oncolytic viral vectors that represent an ideal platform for gene delivery. These viruses can occur either naturally or can be engineered as natural viruses in the laboratory. 230 The first oncolytic virus was approved by the US Food and Drug Administration in 2015. 231 In contrast, non-viral vectors are an alternative to virus-based systems, although they have poor transfection efficiency compared to viral vectors. Non-viral vectors, such as polymers, show significantly lower cytotoxicity. They are able to carry large DNA molecules and can be produced costeffectively in large quantity. 232, 233 These vectors are generally prepared by both chemical and physical methods. Physical methods are usually performed via physical force to increase permeability of the cell membrane. The most important physical methods are microinjection, electroporation, ultrasound, and gene gun. 234, 235 Chemical methods utilize cationic polymers, cationic lipids, liposomes, and cell-penetrating peptides to deliver genes into cells. [236] [237] [238] Many gene delivery systems have been designed based on cationic polymers, such as PEI. [239] [240] [241] Due to pH buffering capacity, this polymer is one of the most important non-viral polymeric vectors for gene delivery. This sustainable buffering capacity below physiological pH helps condense DNA to escape the endosomal barrier while avoiding lysosomal degradation. 242 PEI due to lack of degradability has high toxicity for biomedical applications. To solve this problem, a number of PEI polymers with biodegradable segments in their backbone have been synthesized. Graphene is also used to design non-viral gene transfer systems. These systems have been proposed as efficient 2D non-viral gene transfer vectors, because their outstanding properties 243 such as facile and versatile chemical functionalization, protection of nucleic acid from enzymatic degradation, and fast cellular uptake result in efficient gene transfection into the target cells. [244] [245] [246] In order to improve the biocompatibility and bio-stability of graphene platforms as well as their ability for the efficient transfection of genes, they have been modified with various polymers and ligands. 247, 248 There are a large number of studies regarding graphenepolymer platforms for gene delivery application. In 2018, an efficient non-viral gene delivery system was designed using PEI functionalized GO (GO-PEI) loaded with miR-7b by Dou et al which exhibited excellent transfection efficiency with low cytotoxicity. 249 The results have shown that GO-PEI could efficiently deliver miR-7b plasmid into bone marrow macrophages. Animal study has demonstrated that preserved preosteoclast by GO-PEI-miR-7b enhanced bone vascularization in ovariectomized mice. GO-PEI nanostructure has been fabricated as a gene delivery and bioimaging vector by Kim et al. 250 Polyethylenimine as a cationic polymer, which has been widely used as a non-viral gene delivery vector, is conjugated to GO surface to improve its interactions with negatively charged genes. Combination of branched PEI and GO results in a hybrid system with enhanced transfection efficiency and photoluminescence property for simultaneous gene delivery and bioimaging (Figure 12 ). Branched PEI exhibits high transfection efficiency due to enhanced cellular uptake and a high level of endosomal escape. However, due to the high cytotoxicity of high molecular weight branched PEI (HMWBPEI), their use as effective gene delivery systems is limited. In contrast, low molecular weight branched PEI (HMWBPEI) shows poor transfection efficacy, while it has low cytotoxicity. When LMW BPEI is conjugated to GO, it demonstrated good cellular uptake and transfection efficiency with low cytotoxicity. The gene transfection efficiency is evaluated using luciferase gene expression assays. The results exhibited a low gene transfection for the individual pristine GO and LMW BPEI and a high transfection for HMW BPEI and BPEI-GO. High transfection efficiency of BPEI-GO is due to the effect of LMW BPEI conjugated to GO and formation of a stable polyelectrolyte complex with plasmid DNA. In general, it can be concluded that polymer-functionalized graphene-based carriers have been widely applied in 251 osteoporosis, 252 and myocardial infarction. 253 A variety of macromolecules including cationic polymers, dendrimers, chitosan, and peptides have been used to modify graphene derivatives for efficient gene transfection. [254] [255] [256] Graphene derivatives with high surface area provide ideal platforms to immobilize various metal nanoparticles (MNPs) including Au, Fe, Pt, Gd, Pd, etc. in a sheet-like structure. 257, 258 Graphene/metal hybrids are investigated extensively for cancer therapy and imaging including photoacoustic imaging, PTT, thermomechanical, and surface enhanced Raman signals (SERS). Various approaches including in situ reduction, hydrothermal, electrochemical, physical vapor deposition, ex situ and wrapping MNPs have been reported to synthesize graphene/metal hybrids. 259 In this regard, graphene-AuNPs hybrids have attracted a great deal of attention for various medical applications owing to their unique optoelectronic properties. [260] [261] [262] Graphene-AuNPs hybrids are used as biosensors for the detection and diagnosis of cancer cells, due to their prominent surface plasmon resonance (SPR), 263 NIR emission, quenching effect, adsorption of bioreceptors, enzyme mimic-peroxidase activities, improved electron transfer rate, and conductivity of both graphene and AuNPs. 264 Moreover, GO-AuNPs are reported as electrochemical immunosensors for detection of various cancer markers including CEA, CA125, P53, PSA, AFP, and Vascular endothelial growth factor (VEGF) 150. [265] [266] [267] As an example, rGO/thionine/AuNPs hybrid has been used to fabricate immunosensors for the detection of cancer antigen 125 (CA125). 268 This fabricated immunosensor has demonstrated low detection limits (0.01 U mL-1), high reliability and accuracy. Moreover, various hybrids of GO-AuNPs are explored for fabrication of genobiosensors for detection of DNA, miRNA-21, and plasma miR-155. [269] [270] [271] On the other hand, graphene/AuNPs are widely used for photothermal therapy (PTT) and photodynamic therapy (PDT) owing to the synergic effect of both components such as strong NIR optical absorption, high NIR light-to-heat conversion, and ROS production. 272, 273 Magnetic graphene hybrids, particularly graphene/iron oxide, have shown synergistic therapeutic effect. 274, 275 It is demonstrated that graphene/Fe 2 O 3 NPs hybrids can serve as MRI contrast and diagnosis agents. 276, 277 Besides efficient diagnostic applications, graphene/Fe 2 O 3 NPs hybrids have been investigated as magnetically targeted drug delivery systems with simultaneous photothermal effect. 278, 279 Many 5970 studies have shown that drug-loaded graphene/Fe 2 O 3 systems can be effectively accumulated at the targeted tumor site by applying an external magnetic field. 275, 280, 281 Moreover, under external magnetic field these systems have exhibited enhanced release of the drug at the targeted tumor site owing to heat generated by the Fe 3 O 4 NPs and deformation of the nanocarrier. Based on these outcomes, magnetic graphene hybrids have been supposed as safe and excellent tools for imaging of cancer cells, drug delivery, and hyperthermia. 279, [282] [283] [284] [285] Lanthanide-based nanomaterials, particularly gadolinium, are another class of widely explored metals as contrast agents in MRI. [286] [287] [288] Conjugation of gadolinium onto the surface of graphene-based materials endows new properties and enhances their magnetic, luminescence, and therapeutic properties. Due to its outstanding properties, graphene/GdNPs hybrid is one of the most promising nanomaterials for biomedicine applications including photodynamic/photothermal therapy, biosensing, and bioimaging. 289, 290 Extensive studies have pointed out that Pd-based nanomaterials are excellent platforms for promoting the chemotherapeutic effects of graphene drug delivery systems. Tumor model studies have shown a high performance of graphene/ PdNPs hybrids for diagnosis and treatment of cancers. 291, 292 This review aims to explain the advantages and recent progresses in graphene-based platforms for different biomedical applications including drug and gene delivery as well as bioimaging. There is a great deal of attention to use graphene and its derivatives in biomedicine. However, an extensive study on the toxicity and health risks of this class of nanomaterials should be performed to diminish the risk of their long-term side effects. To achieve this goal, the key point is to produce a highly defined graphene family in terms of number of layers, surface area, and functionality. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Causes of death among cancer patients Incidence and mortality of various cancers in Iran and compare to other countries: a review article Cancer prevention from the perspective of global cancer burden patterns Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors Classification of malignant and benign tissue with logistic regression Automated classification of pulmonary nodules through a retrospective analysis of conventional CT and two-phase PET images in patients undergoing biopsy Anticancer drug delivery systems based on specific interactions between albumin and polyglycerol Polyamidoamine and polyglycerol; their linear, dendritic and linear-dendritic architectures as anticancer drug delivery systems Innovative approaches for cancer treatment: current perspectives and new challenges The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer Combination of chemotherapy and Au-nanoparticle photothermy in the visible light to tackle doxorubicin resistance in cancer cells Circumventing tumor resistance to chemotherapy by nanotechnology Directed graphene-based nanoplatforms for hyperthermia: overcoming multiple drug resistance Size-tunable strategies for a tumor targeted drug delivery system Self-assembled nanomaterials for enhanced phototherapy of cancer Nanomaterials for cancer therapies Hyperbranched poly (citric acid) and its application as anticancer drug delivery system Nanoparticle-based drug delivery systems for cancer therapy pH-sensitive supramolecular copolydendrimers, new anticancer drug delivery system Polymerfunctionalized carbon nanotubes in cancer therapy: a review Carbon nanotubes in cancer therapy: a more precise look at the role of carbon nanotube-polymer interactions Two-dimensional MoS 2: a platform for constructing three-dimensional structures using RAFT polymerization Metal-assisted and solvent-mediated synthesis of two-dimensional triazine structures on Gram Scale Boronic acid-functionalized two-dimensional MoS2 at biointerfaces Low temperature functionalization of two-dimensional boron nitride for electrochemical sensing Gram scale and room temperature functionalization of boron nitride nanosheets for water treatment Covalent decoration of MoS2 platforms by silver nanoparticles through the reversible addition-fragmentation chain transfer reaction Nano based drug delivery systems: recent developments and future prospects Graphene as cancer theranostic tool: progress and future challenges A review on graphene-based nanomaterials in biomedical applications and risks in environment and health Self-degrading graphene sheets for tumor therapy Graphene-dendritic polymer hybrids: synthesis, properties, and applications Detection of individual gas molecules adsorbed on graphene Application of graphene in energy storage device-A review Graphene-based composites for electrochemical energy storage Printable and flexible graphene pH sensors utilising thin film melanin for physiological applications Graphenepolyaniline composite as superior electrochemical sensor for detection of cyano explosives Graphene-based materials for biosensors: a review Graphene-based nanomaterials: biological and medical applications and toxicity Graphene and graphene oxide as nanomaterials for medicine and biology application Functionalized nanographene sheets with high antiviral activity through synergistic electrostatic and hydrophobic interactions Construction and evaluation of a self-calibrating multiresponse and multifunctional graphene biosensor Thermoresponsive amphiphilic functionalization of thermally reduced graphene oxide to study graphene/bacteria hydrophobic interactions Mechanistic understanding of the interactions between nano-objects with different surface properties and α-synuclein Convenient method for preparation of a new absorbent based on biofunctionalized graphene oxide hydrogels using nitrene chemistry and click reaction Emerging 2D material-based nanocarrier for cancer therapy beyond graphene Functionalization of graphene family nanomaterials for application in cancer therapy A dynamically tunable plasmonic multi-functional device based on graphene nano-sheet pair arrays Methodology for the design of a multi-functional device with switchable absorption and polarization conversion modes by graphene and metallic metasurfaces Multivalent interactions between 2D nanomaterials and biointerfaces Curcumin complexed with graphene derivative for breast cancer therapy Amplified activity of artesunate mediated by iron oxide nanoparticles loaded on a graphene oxide carrier for cancer therapeutics Simultaneous delivery of antimiR-21 and doxorubicin by graphene oxide for reducing toxicity in cancer therapy Mechanical properties of graphene oxides Applications of graphene oxide in case of nanomedicines and nanocarriers for biomolecules: review study Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells A novel ECL biosensor for the detection of concanavalin A based on glucose functionalized NiCo2S4 nanoparticles-grown on carboxylic graphene as quenching probe Graphene-ruthenium (II) complex composites for sensitive ECL immunosensors Dynamic evaluation of cell-secreted interferon gamma in response to drug stimulation via a sensitive electro-chemiluminescence immunosensor based on a glassy carbon electrode modified with graphene oxide, polyaniline nanofibers, magnetic beads, and gold nanoparticles Sensitive and selective DNA probe based on "turn-on" photoluminescence of C-dots@ RGO Recent advances in graphene-based nanomaterials: properties, toxicity and applications in chemistry, biology and medicine Sensitive detection of RNase a activity and collaborative drug screening based on rGO and fluorescence probe CuO/WO3 nanoparticles decorated graphene oxide nanosheets with enhanced peroxidase-like activity for electrochemical cancer cell detection and targeted therapeutics Nano-graphene in biomedicine: theranostic applications Graphene: a versatile nanoplatform for biomedical applications Nanotoxicity of different sizes of graphene (G) and graphene oxide (GO) in vitro and in vivo Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2 Size-dependent genotoxicity of graphene nanoplatelets in human stem cells The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts Cell specific cytotoxicity and uptake of graphene nanoribbons In vitro and in vivo effects of graphene oxide and reduced graphene oxide on glioblastoma Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule Graphene in the aquatic environment: adsorption, dispersion, toxicity and transformation Graphene-based antibacterial paper In vivo compatibility of graphene oxide with differing oxidation states Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties In vitro and in vivo behaviors of dextran functionalized graphene Aminated graphene oxide as a potential new therapy for colorectal cancer Covalent functionalization of graphene with reactive intermediates Synthesis of polymer-functionalized nanoscale graphene oxide with different surface charge and its cellular uptake, biosafety and immune responses in Raw264. 7 macrophages Polyethylene glycol (PEG) decorated graphene oxide nanosheets for controlled release curcumin delivery PEGylation of reduced graphene oxide induces toxicity in cells of the bloodbrain barrier: an in vitro and in vivo study In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice Cancer nanomedicine: progress, challenges and opportunities Physiologically based pharmacokinetic modeling of nanoparticles Surface charge controls the suborgan biodistributions of gold nanoparticles Raman spectroscopy for the detection of organ distribution and clearance of PEGylated reduced graphene oxide and biological consequences Bioaccumulation and toxicity of 13C-skeleton labeled graphene oxide in wheat Pharmacokinetics study of isorhamnetin in rat plasma by a sensitive electrochemical sensor based on reduced graphene oxide In vivo pharmacokinetics, transfer and clearance study of graphene oxide by La/Ce dual elemental labelling method Recent progress in graphene/ polymer nanocomposites Graphene-polymer nanocomposites for biomedical applications Biomedical applications of graphene-based structures Graphene sheets with defined dual functionalities for the strong SARS-CoV-2 interactions Biomedical application of graphene: from drug delivery, tumor therapy Graphene-dendritic polymer hybrids: synthesis, properties, and applications Graphene oxidepolymer gels Scalable production of nanographene and doping via nondestructive covalent functionalization One-pot exfoliation, functionalization, and size manipulation of graphene sheets: efficient system for biomedical applications Controlled covalent functionalization of thermally reduced graphene oxide to generate defined bifunctional 2D nanomaterials Preparation of graphene oxide by cyanuric chloride as an effective and non-corrosive oxidizing agent Enzymatic functionalization of nanomaterials: a strategy for engineering their surfaces Functionalization of graphene: covalent and non-covalent approaches, derivatives and applications Functionalization of graphene oxide and its biomedical applications Nitrene addition to exfoliated graphene: a one-step route to highly functionalized graphene Scalable functional group engineering of carbon nanotubes by improved one-step nitrene chemistry Preserving π-conjugation in covalently functionalized carbon nanotubes for optoelectronic applications Functionalized graphene as extracellular matrix mimics: toward well-defined 2D nanomaterials for multivalent virus interactions PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity Covalent functionalization of graphene oxide with biocompatible poly (ethylene glycol) for delivery of paclitaxel PEGAylated graphene oxide/superparamagnetic nanocomposite as a high-efficiency loading nanocarrier for controlled delivery of methotrexate Polyethylenimine coated graphene oxide nanoparticles for targeting mitochondria in cancer cells Engineered polyethylenimine/graphene oxide nanocomposite for nuclear localized gene delivery Graphene oxide based functionalized chitosan polyelectrolyte nanocomposite for targeted and pH responsive drug delivery Co-delivery of doxorubicin and curcumin by a pH-sensitive, injectable, and in situ hydrogel composed of chitosan, graphene, and cellulose nanowhisker β-Cyclodextrin-cholic acidhyaluronic acid polymer coated Fe3O4-graphene oxide nanohybrids as local chemo-photothermal synergistic agents for enhanced liver tumor therapy Hyaluronic acid functionalized green reduced graphene oxide for targeted cancer photothermal therapy A polyamidoamne dendrimer functionalized graphene oxide for DOX and MMP-9 shRNA plasmid co-delivery Engineering of Biomaterials for Drug Delivery Systems A review on nano-based drug delivery system for cancer chemoimmunotherapy Graphene and other 2D materials: a multidisciplinary analysis to uncover the hidden potential as cancer theranostics Functionalized graphene sheets for intracellular controlled release of therapeutic agents PEGylated nanographene oxide for delivery of water-insoluble cancer drugs Delivery of oridonin and methotrexate via PEGylated graphene oxide Effective PEGylation method to improve biocompatibility of graphene derivatives Direct measurements of the interaction between pyrene and graphite in aqueous media by single molecule force spectroscopy: understanding the π− π interactions Multifunctional nanographene oxide for targeted gene-mediated thermochemotherapy of drug-resistant tumour Hybrid graphene oxide as carrier of doxorubicin: cytotoxicity and preliminary in vivo assays against bladder cancer An ultrasensitive non-enzymatic sensor for quantitation of anti-cancer substance chicoric acid based on bimetallic nanoalloy with polyetherimide-capped reduced graphene oxide Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer Design and evaluation of biological gate circuits and their therapeutic applications in a model of multidrug resistant cancers Characterization of synergistic anti-tumor effects of doxorubicin and p53 via graphene oxide-polyethyleneimine nanocarriers β-Cyclodextrin grafted magnetic graphene oxide applicable as cancer drug delivery agent: synthesis and characterization Synthesis and characterization of graphene-grafted gelatin nanocomposite hydrogels as emerging drug delivery systems Folic acid-grafted bovine serum albumin decorated graphene oxide: an efficient drug carrier for targeted cancer therapy Incorporating graphene oxide into biomimetic nano-microfibrous cellulose scaffolds for enhanced breast cancer cell behavior Engineering the pH-sensitivity of the graphene and carbon nanotube based nanomedicines in smart cancer therapy by grafting trimetyl Chitosan Chitosan-grafted-poly (methacrylic acid)/graphene oxide nanocomposite as a pH-responsive de novo cancer chemotherapy nanosystem A critical comparison study on the pH-sensitive nanocomposites based on graphene-grafted chitosan for cancer theragnosis 5-Fluorouracil and curcumin co-encapsulated chitosan/reduced graphene oxide nanocomposites against human colon cancer cell lines Design and development of graphene oxide nanoparticle/chitosan hybrids showing pH-sensitive surface charge-reversible ability for efficient intracellular doxorubicin delivery Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery Surface modification of graphene oxide nanosheets by protamine sulfate/sodium alginate for anti-cancer drug delivery application Fabrication of new generation of co-delivery systems based on graphene-g-cyclodextrin/chitosan nanofiber β-Cyclodextrin modified graphene oxide-magnetic nanocomposite for targeted delivery and pH-sensitive release of stereoisomeric anti-cancer drugs Layer-by-layer modification of magnetic graphene oxide by chitosan and sodium alginate with enhanced dispersibility for targeted drug delivery and photothermal therapy Chitosan and dextran stabilized GO-iron oxide nanosheets with high dispersibility for chemotherapy and photothermal ablation Non-covalent modification of graphene oxide nanocomposites with chitosan/dextran and its application in drug delivery Fabrication of chitosan/poly (lactic acid)/graphene oxide/TiO2 composite nanofibrous scaffolds for sustained delivery of doxorubicin and treatment of lung cancer Chitosan/sodium alginate modificated graphene oxide-based nanocomposite as a carrier for drug delivery Hyaluronic acid and Arg-Gly-Asp peptide modified graphene oxide with dual receptor-targeting function for cancer therapy Redox sensitive hyaluronic aciddecorated graphene oxide for photothermally controlled tumorcytoplasm-selective rapid drug delivery Hyaluronic acid-based nanomaterials for cancer therapy Hyaluronic acid-coated nanomedicine for targeted cancer therapy Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy Functionalized 2D nanomaterials with switchable binding to investigate graphene-bacteria interactions Combination of surface charge and size controls the cellular uptake of functionalized graphene sheets Edge-functionalization of graphene by polyglycerol A way to change its flat topology Nano-graphene oxide for cellular imaging and drug delivery Aptamer-functionalized magnetic graphene oxide nanocarrier for targeted drug delivery of paclitaxel Functionalization of reduced graphene oxide via thiol-maleimide "click" chemistry: facile fabrication of targeted drug delivery vehicles A targeted drug delivery system based on dopamine functionalized nano graphene oxide Lactoferrin modified graphene oxide iron oxide nanocomposite for glioma-targeted drug delivery Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery Polymer vesicles: modular platforms for cancer theranostics Graphene-based smart platforms for combined Cancer therapy Graphene platforms for smart energy generation and storage Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy Graphene-based smart materials pH-responsive hybrid hydrogels as antibacterial and drug delivery systems pH-sensitive drug-delivery systems for tumor targeting pH-sensitive nanocargo based on smart polymer functionalized graphene oxide for site-specific drug delivery pH-sensitive nano-systems for drug delivery in cancer therapy Multistage nanovehicle delivery system based on stepwise size reduction and charge reversal for programmed nuclear targeting of systemically administered anticancer drugs Dual-pH sensitive charge-reversal polypeptide micelles for tumor-triggered targeting uptake and nuclear drug delivery Charge-reversal drug conjugate for targeted cancer cell nuclear drug delivery Glutathione dysregulation and the etiology and progression of human diseases Metabolism and functions of glutathione in brain Redox-sensitive prodrug molecules meet graphene oxide: an efficient graphene oxide-based nanovehicle toward cancer therapy External-stimuli responsive systems for cancer theranostic Design and Evaluation of a GUI for Signal and Data Analysis of Mobile Functional Near-Infrared Spectroscopy Systems Micro-optical components for bioimaging on tissues, cells and subcellular structures Organic-inorganic nanohybrids for fluorescence, photoacoustic and Raman bioimaging Newly-engineered materials for bio-imaging technology: a focus on the hybrid system of ultrasound and fluorescence In situ electron microscopy of complex biological and nanoscale systems: challenges and opportunities Applications of graphene and its derivatives in intracellular biosensing and bioimaging Photoswitchable single-walled carbon nanotubes for super-resolution microscopy in the near-infrared Graphene and its derivatives-based optical sensors A multi-fluorescent DNA/graphene oxide conjugate sensor for signature-based protein discrimination Photoluminescent graphene nanoparticles for cancer phototherapy and imaging Fluorescence and sensing applications of graphene oxide and graphene quantum dots: a review High-contrast visualization of graphene oxide on dye-sensitized glass, quartz, and silicon by fluorescence quenching Fluorescence quenching in conjugated polymers blended with reduced graphitic oxide Control of the grapheneprotein interface is required to preserve adsorbed protein function Multi-functional graphene as an in vitro and in vivo imaging probe Recent advances on graphene quantum dots for bioimaging applications Graphene-based scaffolds for regenerative medicine Graphene oxide based surface-enhanced Raman scattering probes for cancer cell imaging Multifunctional poly (l-lactide)-polyethylene glycol-grafted graphene quantum dots for intracellular microRNA imaging and combined specific-gene-targeting agents delivery for improved therapeutics Graphene family nanomaterials for application in cancer combination photothermal therapy Graphene-based scaffolds for tissue engineering and photothermal therapy Photothermal applications based on graphene and its derivatives: a state-of-the-art review Functionalized graphene nanocomposites for enhancing photothermal therapy in tumor treatment Reversible photothermal homogenization of fluorous biphasic systems with perfluoroalkylated nanographene Graphene-polyglycerol-curcumin hybrid as a near-infrared (NIR) laser stimuliresponsive system for chemo-photothermal cancer therapy Reduced graphene oxide nanosheet for chemo-photothermal therapy Three dimensional mesoporous carbon nanospheres as carriers for chemo-photothermal therapy compared with two dimensional graphene oxide nanosheets Folic acid-conjugated chitosan-functionalized graphene oxide for highly efficient photoacoustic imaging-guided tumor-targeted photothermal therapy PEGylated reduced-graphene oxide hybridized with Fe 3 O 4 nanoparticles for cancer photothermal-immunotherapy Carbon-based materials for photodynamic therapy: a mini-review Photodynamic-based therapeutic modalities to fight against cancer-A review from synergistic viewpoint Fabrication of a graphene/C 60 nanohybrid via γ-cyclodextrin host-guest chemistry for photodynamic and photothermal therapy Comparison of nanomedicine-based chemotherapy, photodynamic therapy and photothermal therapy using reduced graphene oxide for the model system Aggregation-induced emission nanoparticles encapsulated with PEGylated nano graphene oxide and their applications in two-photon fluorescence bioimaging and photodynamic therapy in vitro and in vivo Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma Photodynamic therapy using graphene quantum dot derivatives Gene therapy leaves a vicious cycle Advances in gene delivery systems Non viral vectors in gene therapy-an overview RNA-based viral vectors A century of oncolysis evolves into oncolytic immunotherapy Cancer-fighting viruses win approval Peptide-based gene delivery vectors Interleukin-12 plasmid DNA delivery using l-thyroxine-conjugated polyethylenimine nanocarriers Non-viral in vitro gene delivery: it is now time to set the bar! Pharmaceutics Physical methods for intracellular delivery: practical aspects from laboratory use to industrial-scale processing Barriers and strategies of cationic liposomes for cancer gene therapy Green transfection: cationic lipid nanocarrier system derivatized from vegetable fat, palm stearin enhances nucleic acid transfections Cell penetrating peptides, novel vectors for gene therapy Library of cationic polymers composed of polyamines and arginine as gene transfection agents Nonviral gene delivery with cationic glycopolymers Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon ATP-responsive low-molecular-weight polyethylenimine-based supramolecular assembly via host-guest interaction for gene delivery Graphene materials as 2D non-viral gene transfer vector platforms Functionalizedgraphene composites: fabrication and applications in sustainable energy and environment Graphene oxide as a nanocarrier for biochemical molecules: current understanding and trends Cellular uptake of mildly oxidized nanographene for drug-delivery applications Applications of graphene and graphene oxide in smart drug/ gene delivery: is the world still flat? Graphene-based nano-carrier modifications for gene delivery applications Graphene-based microRNA transfection blocks preosteoclast fusion to increase bone formation and vascularization Graphene oxide-polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool SiRNA delivery with PEGylated graphene oxide nanosheets for combined photothermal and genetherapy for pancreatic cancer Osteoblast-targeting-peptide modified nanoparticle for siRNA/microRNA delivery Injectable graphene oxide/ hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro Graphene oxide-chitosan nanocomposites for intracellular delivery of immunostimulatory CpG oligodeoxynucleotides Graphene oxide nanosheets in complex with cell penetrating peptides for oligonucleotides delivery Metal-graphene interfaces in epitaxial and bulk systems: a review Electrical properties of graphene-metal contacts Graphene-inorganic nanocomposites Graphene-gold based nanocomposites applications in cancer diseases; Efficient detection and therapeutic tools The bio-interface between functionalized Au NR@ GO nanoplatforms with protein corona and their impact on delivery and release system Multifunctional core-shell nanoplatforms (gold@ graphene oxide) with mediated NIR thermal therapy to promote miRNA delivery Nanocomposites of size-controlled gold nanoparticles and graphene oxide: formation and applications in SERS and catalysis A simple approach for immobilization of gold nanoparticles on graphene oxide sheets by covalent bonding Label-free electrochemical immunosensor based on one-step electrochemical deposition of AuNP-RGO nanocomposites for detection of endometriosis marker CA 125 Ultrasensitive nonenzymatic immunosensor based on bimetallic gold-silver nanoclusters synthesized by simple mortar grinding route Electrochemical immunosensor for carcinoembryonic antigen based on nanosilver-coated magnetic beads and gold-graphene nanolabels A paper-based electrochemical immunosensor with reduced graphene oxide/thionine/gold nanoparticles nanocomposites modification for the detection of cancer antigen 125 Electrochemical detection of Salmonella using an invA genosensor on polypyrrole-reduced graphene oxide modified glassy carbon electrode and AuNPs-horseradish peroxidase-streptavidin as nanotag Dual-modal label-free genosensor based on hemoglobin@ gold nanocluster stabilized graphene nanosheets for the electrochemical detection of BCR/ABL fusion gene Immobilization of ssDNA on the surface of silver nanoparticles-graphene quantum dots modified by gold nanoparticles towards biosensing of microorganism A sandwich nanostructure of gold nanoparticle coated reduced graphene oxide for photoacoustic imaging-guided photothermal therapy in the second NIR window Simulated sunlight-mediated photodynamic therapy for melanoma skin cancer by titanium-dioxide-nanoparticle-gold-nanocluster-graphene heterogeneous nanocomposites A reusable magnetic graphene oxide-modified biosensor for vascular endothelial growth factor detection in cancer diagnosis Magnetic graphene oxide as a carrier for targeted delivery of chemotherapy drugs in cancer therapy Multifunctional graphene oxide/iron oxide nanoparticles for magnetic targeted drug delivery dual magnetic resonance/fluorescence imaging and cancer sensing Enhancing the magnetic relaxivity of MRI contrast agents via the localized superacid microenvironment of graphene quantum dots Nanoscale metalorganic frameworks decorated with graphene oxide for magnetic resonance imaging guided photothermal therapy Magnetic-induced graphene quantum dots for imaging-guided photothermal therapy in the second near-infrared window Drug-loaded dual targeting graphene oxide-based molecularly imprinted composite and recognition of carcino-embryonic antigen β-cyclodextrin-hyaluronic acid polymer functionalized magnetic graphene oxide nanocomposites for targeted photo-chemotherapy of tumor cells Hyperthermia response of PEGylated magnetic graphene nanocomposites for heating applications and accelerate antibacterial activity using magnetic fluid hyperthermia Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy Paramagnetic properties of metal-free boron-doped graphene quantum dots and their application for safe magnetic resonance imaging Magnetic graphene oxide inlaid with silver nanoparticles as antibacterial and drug delivery composite Gadolinium-encapsulated graphene carbon nanotheranostics for imaging-guided photodynamic therapy Engineering of gadolinium-decorated graphene oxide nanosheets for multimodal bioimaging and drug delivery Engineered gadolinium-based nanomaterials as cancer imaging agents Manganese-nitrogen and gadolinium-nitrogen Codoped graphene quantum dots as bimodal magnetic resonance and fluorescence imaging nanoprobes Graphene oxide as a nanocarrier for a theranostics delivery system of protocatechuic acid and gadolinium/gold nanoparticles Palladium nanoparticle-decorated 2-D graphene oxide for effective photodynamic and photothermal therapy of prostate solid tumors Electrochemical detection of cancer cells in human blood using folic acid and glutamic acid-functionalized graphene quantum dot-palladium@ gold as redox probe with excellent electrocatalytic activity and target recognition The authors would like to thank Iran's Science Elites Federation for their financial support. The authors reported no conflicts of interest for this work. The International Journal of Nanomedicine is an international, peerreviewed journal focusing on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. This journal is indexed on PubMed Central, MedLine, CAS, SciSearch ® , Current Contents ® /Clinical Medicine, Journal Citation Reports/Science Edition, EMBase, Scopus and the Elsevier Bibliographic databases. The manuscript management system is completely online and includes a very quick and fair peer-review system, which is all easy to use. Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.